Jean-François R.
- Country
- France
- Department
- Cardiologist
Research Overview
- A Phase 3, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Levosimendan in Patients with Pulmonary Hypertension and HFpEF
- Efficacy of Dapagliflozin on Cardiac Systolic Function and Remodeling in Acute Myocardial Infarction Patients with Left Ventricular Dysfunction
- Efficacy and Safety of Colchicine and Carbaspirin Calcium in Cardiovascular Outcomes for Type 2 Diabetes Patients Without Prior Cardiovascular Events
Data & Insights
Has run more than one trial at 10 of 117 partner sites.
Specializations
Cardiovascular disease and lipid management
JeanFrancois RIVIERE is involved in clinical research on atherosclerotic cardiovascular disease, acute coronary syndrome, myocardial infarction, and cardiovascular risk reduction, with additional interest in atrial fibrillation, hypertension, and heart failure.
- Secondary prevention after PCI
- LDL-C lowering
- Lipoprotein(a)
- Stroke prevention
His research landscape also includes renal denervation, cardiac remodeling after infarction, and prevention of recurrent cardioembolic events.
Thoracic oncology
His clinical trial activity covers non-small cell lung cancer across early, locally advanced, and metastatic settings, with emphasis on immunotherapy and targeted therapy strategies.
- Resected lung cancer
- Unresectable stage III disease
- BRAF-mutant lung cancer
- Metastatic squamous and non-squamous NSCLC
He is also engaged in research on cutaneous squamous cell carcinoma and advanced melanoma, reflecting a strong focus on precision oncology in thoracic and skin cancers.
Breast and gynecologic oncology
JeanFrancois RIVIERE participates in studies of breast cancer and ovarian cancer, including triple-negative breast cancer, HR-positive HER2-negative breast cancer, and metastatic ovarian cancer.
- Early breast cancer
- Metastatic breast cancer
- High-risk ovarian cancer
- Endocrine therapy
His work also extends to molecularly guided treatment, including biomarker-informed approaches in hormone receptor-positive disease and recurrence prevention.
Gastrointestinal and hepatobiliary oncology
His research interests include colorectal cancer, rectal cancer, small bowel adenocarcinoma, biliary tract cancer, and hepatocellular carcinoma, spanning both localized and advanced disease.
- Colon and rectal cancer
- Biliary tract malignancies
- Pancreatic adenocarcinoma
- Metastatic gastrointestinal cancer
He is also involved in studies of perioperative treatment, chemotherapy optimization, and immunotherapy combinations in gastrointestinal oncology.
Inflammatory, autoimmune, and infectious diseases
JeanFrancois RIVIERE contributes to clinical research in ulcerative colitis, rheumatoid arthritis, systemic sclerosis, multiple sclerosis, and selected infectious diseases.
- Inflammatory bowel disease
- Autoimmune rheumatic disease
- Systemic sclerosis-associated lung disease
- Early syphilis
His trial portfolio also includes bronchiectasis, postoperative infection prevention, and vascular inflammatory disorders such as Raynaud phenomenon and vitiligo.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.